awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35803555-1B3467E2-2807-447A-95DA-917B65FDACED
Q35803555-1B3467E2-2807-447A-95DA-917B65FDACED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35803555-1B3467E2-2807-447A-95DA-917B65FDACED
Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy.
P2860
Q35803555-1B3467E2-2807-447A-95DA-917B65FDACED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35803555-1B3467E2-2807-447A-95DA-917B65FDACED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
401a9eb54f10fef578a70c005596edfefddedd2a
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).